article thumbnail

How my experience as a patient helped shape NICE guidelines for colorectal cancer

NICE

Contributing my personal experience to the discussion, I shared my experience of developing chronic peripheral neuropathy, which came about as a side effect following chemotherapy. My experiences were supported by the research results - which led to a reduction in dosage from 6 months to 3 in the NICE guideline.

Dosage 52
article thumbnail

International regulation: the importance of quality assurance in drug development

European Pharmaceutical Review

Since the first ADC was approved by the EMA in 2012, they have generated a great deal of interest in the oncology field because of their potential to address many of the challenges of traditional chemotherapy options. She has worked at organisations including Merck, Novartis, Schering-Plough, and Endo Pharmaceuticals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Apixaban vs warfarin: rise of newer anticoagulant

Druggist

Additionally, the dosage is much simpler as compared to warfarin as it does not change generally after treatment initiation is completed. . Patients who have cancer or receive chemotherapy. When INR changes, patients need to adjust their dose by increasing or decreasing the number of warfarin tablets they take.

Dosage 98
article thumbnail

SPuMoNI: Enhancing Pharma Data Quality through Smart Technologies

ISPE

Although the pharmaceutical industry has consistently improved manufacturing processes 3 in compliance with good manufacturing practices, 4 there are documented deviations from good practices 5 including the continued falsification of medicines. Mexican Governor: Cancer Children Given Water Instead of Chemotherapy.” Lakerveld, B.

Dosage 52